Beauty stocks fell this week as E.l.f. Beauty and Estee Lauder issued disappointing guidance.
COTY's Q2 results are likely to reflect the adverse impact of weakness across the Chinese mainland and Asia Travel Retail.
Besides Wall Street's top -and-bottom-line estimates for Coty (COTY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.
Coty (COTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Coty Inc. has outperformed peers in 9 of the last 13 quarters, reduced debt, and trades at historically low valuations. The company focuses on prestige and consumer beauty segments, with strong brands like Calvin Klein and Gucci, and is expanding in Asia Pacific and Latin America. Risks include potential license terminations and a slowdown in the mass beauty segment, but manageable debt and growth should help recover previous valuations.
Coty stock has underperformed since 2023, but management expects industry recovery and long-term growth, potentially boosting Coty's valuation multiples and stock price. COTY excels in prestige brands, driving growth and better margins, but faces challenges in consumer beauty brands with lower margins and higher competition. Despite a leveraged balance sheet, Coty's revenue and FCF growth projections are promising, with potential for significant returns if the industry stabilizes.
COTY is facing challenges like higher operational costs, weak performance in key international markets and unfavorable currency rates.
COTY is facing challenges like higher costs, struggles in the Chinese Mainland and currency woes, raising concerns about its future growth.
At a time when many stocks are objectively and historically overvalued, many investors are wondering where they should put their investable capital in 2025. Some stocks that should attract your attention are trading for less than $10.
The convergence of the beauty category with the health and wellness segment has increased the addressable market for all players, according to Goldman Sachs.
Examine the evolution of Coty's (COTY) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
DA Davidson lowered the firm's price target on Coty to $12.50 from $14.50 but keeps a Buy rating on the shares after its Q1 earnings miss. The company's organic sales growth of 4.5% was impacted by U.S. mass retailer inventory reductions, U.S. drug store closures, and declines in China and Asia travel retail, reducing sell-in by a few percentage points, with softness also expected to continue in Q2, the analyst tells investors in a research note. The firm adds however that the stock is cheap, trading at 6.5-times expected 2026 EBITDA.